skeletal resistance
Recently Published Documents


TOTAL DOCUMENTS

25
(FIVE YEARS 0)

H-INDEX

12
(FIVE YEARS 0)

Author(s):  
Jordi Bover ◽  
Pablo A. Ureña-Torres ◽  
Pieter Evenepoel ◽  
Maria Jesús Lloret ◽  
Lluis Guirado ◽  
...  
Keyword(s):  

2018 ◽  
Author(s):  
xiang chen ◽  
Yang Meng ◽  
Ying Xie ◽  
Shan Wan ◽  
Li Li ◽  
...  

GNAS is one of the most complex gene loci in the human genome and encodes multiple gene products. XLas, the extra-large isoform of alpha-subunit of the stimulatory guanine nucleotide-binding protein (Gas), is paternally inherited. Although XLas can mimic the action of Gas, its significance remains largely unknown in humans. Here we report a patient presented with increased bone mass, hypophosphatemia, and elevated parathyroid hormone levels. His serum calcium was in the lower limit of normal range. DEXA scan revealed progressive increase in the bone density of this patient. Whole exome sequencing of this subject found a novel nonsense mutation c.424G>T (p. G142X) in the first exon of XLas, which was inherited from his father and transmitted to his daughter. This mutation was predicted to exclusively influence the expression of XLas, while may have no significant effects on other gene products of this locus. SaOS2 cells transfected with mutant XLas failed to generate cAMP under parathyroid hormone stimulation, indicating skeletal resistance to this hormone. This subject showed higher circulating SOST, DKK1 and OPG levels, while lower RANKL levels and RANKL/OPG ratio, leading to reduced bone resorption. It is speculated that this patient may belong to a very rare type of pseudohypoparathyroidism with selective skeletal resistance but normal renal tubular response to parathyroid hormone. Our findings indicate that XLas plays a critical role in bone metabolism and GNAS locus should be considered as a candidate gene for high bone mass.


2017 ◽  
Vol 2017 ◽  
pp. 1-11 ◽  
Author(s):  
Yoshiko Iwasaki ◽  
Junichiro James Kazama ◽  
Masafumi Fukagawa

Prevention of bone fractures is one goal of therapy for patients with chronic kidney disease-mineral and bone disorder (CKD-MBD), as indicated by the Kidney Disease: Improving Global Outcomes guidelines. CKD patients, including those on hemodialysis, are at higher risk for fractures and fracture-related death compared to people with normal kidney function. However, few clinicians focus on this issue as it is very difficult to estimate bone fragility. Additionally, uremia-related bone fragility has a more complicated pathological process compared to osteoporosis. There are many uremia-associated factors that contribute to bone fragility, including severe secondary hyperparathyroidism, skeletal resistance to parathyroid hormone, and bone mineralization disorders. Uremia also aggravates bone volume loss, disarranges microarchitecture, and increases the deterioration of material properties of bone through abnormal bone cells or excess oxidative stress. In this review, we outline the prevalence of fractures, the interaction of CKD-MBD with osteoporosis in CKD patients, and discuss possible factors that exacerbate the mechanical properties of bone.


2016 ◽  
Vol 42 (1) ◽  
pp. 44-48 ◽  
Author(s):  
Mario Cozzolino ◽  
Francesca Elli ◽  
Stefano Carugo ◽  
Paola Ciceri

Hyperphosphatemia, hypocalcemia and vitamin D deficiency are the main factors involved in the pathogenesis of secondary hyperparathyroidism (SHPT). Moreover, the skeletal resistance to parathyroid hormone is not only a high-turnover bone accompanying SHPT, but may also play a crucial role in the onset of low-turnover bone disease in uremia. However, a growing body of evidence suggests that other hormones play a key role in this disease, such as fibroblast growth factor 23, Klotho and sclerostin. SHPT causes both bone-associated and non-skeletal consequences, including cardiovascular calcifications. Furthermore, vitamin D and calcium (Ca)-containing phosphate binders may increase Ca load. Anyway, the rate of parathyroidectomy in end-stage renal disease has greatly decreased during the last decade. Is there any room left for surgeons?


2010 ◽  
Vol 14 (4) ◽  
pp. 417-423 ◽  
Author(s):  
Shunsuke Goto ◽  
Hideki Fujii ◽  
Yasuhiro Hamada ◽  
Kunihiko Yoshiya ◽  
Masafumi Fukagawa

2007 ◽  
Vol 22 (8) ◽  
pp. 1271-1279 ◽  
Author(s):  
Jay J Cao ◽  
Pamela Kurimoto ◽  
Benjamin Boudignon ◽  
Clifford Rosen ◽  
Florence Lima ◽  
...  

2007 ◽  
Vol 71 (8) ◽  
pp. 738-743 ◽  
Author(s):  
T. Nii-Kono ◽  
Y. Iwasaki ◽  
M. Uchida ◽  
A. Fujieda ◽  
A. Hosokawa ◽  
...  

Nephrology ◽  
2003 ◽  
Vol 8 ◽  
pp. S50-S52 ◽  
Author(s):  
Masafumi FUKAGAWA ◽  
Yoshiko IWASAKI ◽  
Junichiro J. KAZAMA

Sign in / Sign up

Export Citation Format

Share Document